CNSX:ASTI

Stock Analysis Report

Aquarius Surgical Technologies

Executive Summary

Aquarius Surgical Technologies Inc., through its subsidiary, Surgical Lasers Inc., engages in the development, sale, distribution, marketing, and exploitation of laser-driven technologies in for use in surgical environments, principally in the field of urology in North America.

Snowflake

Fundamentals

Weak fundamentals or lack of information.

Share Price & News

How has Aquarius Surgical Technologies's share price performed over time and what events caused price changes?


Latest Share Price and Events


Market Performance


7 Day Return

0%

ASTI

-4.1%

CA Medical Equipment

-0.2%

CA Market


1 Year Return

-11.1%

ASTI

-19.1%

CA Medical Equipment

1.1%

CA Market

Return vs Industry: ASTI exceeded the Canadian Medical Equipment industry which returned -19.1% over the past year.

Return vs Market: ASTI underperformed the Canadian Market which returned 1.1% over the past year.


Shareholder returns

ASTIIndustryMarket
7 Day0%-4.1%-0.2%
30 Day-11.1%-20.2%-3.3%
90 Day14.3%-20.6%-1.6%
1 Year-11.1%-11.1%-19.1%-19.1%4.6%1.1%
3 Yearn/a-53.2%-53.2%13.1%3.1%
5 Yearn/a-14.8%-14.8%24.7%6.7%

Price Volatility Vs. Market

How volatile is Aquarius Surgical Technologies's share price compared to the market and industry in the last 5 years?


Simply Wall St News

Valuation

Is Aquarius Surgical Technologies undervalued compared to its fair value and its price relative to the market?


In this section, we usually try to help investors determine whether Aquarius Surgical Technologies is trading at an attractive price based on the cash flow it is expected to produce in the future. But as Aquarius Surgical Technologies has not provided consistent financial data, and the stock also has no analyst forecast or coverage, its intrinsic value cannot be reliably calculated by extrapolating past data or using analyst consensus cash flow predictions.

This is quite a rare situation as 89% of companies covered by Simply Wall St do have a valuation analysis.


Next Steps

  • Take a look at our analysis of ASTI’s management and see if the CEO’s compensation is within a reasonable range, who is on the board and if insiders have been trading lately.
  • When valuing a company like this, investors focus more on how they perceive the size of the opportunity, the company's ability to deliver and scale, and the strength of the team. While we are not analysing this type of data at the moment, if you don’t know where to start, we recommend reading through Aquarius Surgical Technologies regulatory filings.
  • Explore potentially undervalued companies in the Healthcare industry.

Future Growth

How is Aquarius Surgical Technologies forecast to perform in the next 1 to 3 years based on estimates from 0 analysts?

59.7%

Forecasted Healthcare industry annual growth in earnings


In this section we usually present revenue and earnings growth projections based on the consensus estimates of professional analysts to help investors understand the company’s ability to generate profit. But as Aquarius Surgical Technologies has not provided enough past data and has no analyst forecast, its future earnings cannot be reliably calculated by extrapolating past data or using analyst predictions.

This is quite a rare situation as 97% of companies covered by SimplyWall St do have past financial data.


Next Steps

Past Performance

How has Aquarius Surgical Technologies performed over the past 5 years?

-66.5%

Historical annual earnings growth


Earnings and Revenue History


Past Earnings Growth Analysis

Earnings Trend: ASTI is unprofitable, and losses have increased over the past 5 years at a rate of -66.5% per year.

Accelerating Growth: Unable to compare ASTI's earnings growth over the past year to its 5-year average as it is currently unprofitable

Earnings vs Industry: ASTI is unprofitable, making it difficult to compare its past year earnings growth to the Medical Equipment industry (27.4%).


Return on Equity

High ROE: ASTI's liabilities exceed its assets, so it is difficult to calculate its Return on Equity.


Return on Assets

ROA vs Industry: ASTI is currently unprofitable, so its Return on Assets is negative.


Return on Capital Employed

ROCE Improving: ASTI is currently unprofitable, so its Return on Capital Employed is negative.


Next Steps

Financial Health

How is Aquarius Surgical Technologies's financial position?


Financial Position Analysis

Short Term Liabilities: ASTI has negative shareholder equity, which is a more serious situation than short term assets not covering short term liabilities.

Long Term Liabilities: ASTI has negative shareholder equity, which is a more serious situation than short term assets not covering long term liabilities.


Debt to Equity History and Analysis

Debt Level: ASTI has negative shareholder equity, which is a more serious situation than a high debt level.

Reducing Debt: ASTI's has negative shareholder equity, so we do not need to check if its debt has reduced over time.


Balance Sheet

Inventory Level: ASTI has a high level of physical assets or inventory.

Debt Coverage by Assets: ASTI has negative shareholder equity (liabilities exceed assets) therefore debt is not covered by short term assets.


Cash Runway Analysis

For companies that have on average been loss making in the past we assess whether they have at least 1 year of cash runway.

Stable Cash Runway: ASTI has less than a year of cash runway based on its current free cash flow.

Forecast Cash Runway: ASTI has less than a year of cash runway if free cash flow continues to reduce at historical rates of -62.4% each year


Next Steps

Dividend

What is Aquarius Surgical Technologies's current dividend yield, its reliability and sustainability?


Dividend Yield vs Market

companyn/amarketbottom25%2.0%markettop25%6.0%industryaverage1.2%forecastin3Yearsn/a

Current dividend yield vs market & industry


Stability and Growth of Payments

Notable Dividend: Unable to evaluate ASTI's dividend yield against the bottom 25% of dividend payers, as the company has not reported any payouts.

High Dividend: Unable to evaluate ASTI's dividend yield against the top 25% of dividend payers, as the company has not reported any payouts.

Stable Dividend: Insufficient data to determine if ASTI's dividends per share have been stable in the past.

Growing Dividend: Insufficient data to determine if ASTI's dividend payments have been increasing.


Current Payout to Shareholders

Dividend Coverage: Insufficient data to calculate payout ratio to determine if its dividend payments are covered by earnings.


Future Payout to Shareholders

Future Dividend Coverage: No need to calculate the sustainability of ASTI's dividend in 3 years as they are not forecast to pay a notable one for the Canadian market.


Next Steps

Management

What is the CEO of Aquarius Surgical Technologies's salary, the management and board of directors tenure and is there insider trading?

2.6yrs

Average management tenure


CEO

N. Van Nest (83yo)

2.6yrs

Tenure

CA$72,000

Compensation

Mr. N. Gary Van Nest, B.Comm., M.B.A. serves as the President of Sinalta Investments Ltd. Mr. Van Nest has over 38 years of extensive experience in the brokerage, merchant banking and investment management ...


CEO Compensation Analysis

Compensation vs. Market: Insufficient data to establish whether N.'s total compensation is reasonable compared to companies of similar size in the Canadian market.

Compensation vs Earnings: N.'s compensation has been consistent with company performance over the past year.


Management Age and Tenure

2.6yrs

Average Tenure

Experienced Management: ASTI's management team is considered experienced (2.6 years average tenure).


Insider Trading

Insider Buying: Insufficient data to determine if insiders have bought more shares than they have sold in the past 3 months.


Recent Insider Transactions

BuyCA$3,20004 Oct 19
David Hennigar
EntityIndividual
Role
Chairman of the Board
Chairman
Shares10,000
Max PriceCA$0.32
BuyCA$4,35007 Feb 19
David Hennigar
EntityIndividual
Role
Chairman of the Board
Chairman
Shares14,500
Max PriceCA$0.30
BuyCA$30004 Feb 19
David Hennigar
EntityIndividual
Role
Chairman of the Board
Chairman
Shares1,000
Max PriceCA$0.30
BuyCA$6,30001 Feb 19
David Hennigar
EntityIndividual
Role
Chairman of the Board
Chairman
Shares21,000
Max PriceCA$0.30
BuyCA$1,30511 Jan 19
David Hennigar
EntityIndividual
Role
Chairman of the Board
Chairman
Shares4,500
Max PriceCA$0.29
BuyCA$2,54009 Jan 19
David Hennigar
EntityIndividual
Role
Chairman of the Board
Chairman
Shares9,000
Max PriceCA$0.30
BuyCA$2,70008 Jan 19
David Hennigar
EntityIndividual
Role
Chairman of the Board
Chairman
Shares9,000
Max PriceCA$0.30
BuyCA$30004 Jan 19
David Hennigar
EntityIndividual
Role
Chairman of the Board
Chairman
Shares1,000
Max PriceCA$0.30
BuyCA$40018 Nov 18
David Hennigar
EntityIndividual
Role
Chairman of the Board
Chairman
Shares1,000
Max PriceCA$0.40
BuyCA$35,45014 Nov 18
David Hennigar
EntityIndividual
Role
Chairman of the Board
Chairman
Shares93,000
Max PriceCA$0.42

Ownership Breakdown


Management Team

  • Christopher Freeman

    Secretary

    • Tenure: 0yrs
  • N. Van Nest (83yo)

    CEO & Vice Chairman

    • Tenure: 2.6yrs
    • Compensation: CA$72.00k
  • Stanley Swierzewski

    Chief of Urology & Director

    • Tenure: 2.6yrs
  • Lorne MacFarlane

    Chief Financial Officer

    • Tenure: 9.9yrs
  • Gordon Willox

    President & CTO

    • Tenure: 0.9yrs
    • Compensation: CA$228.00k

Board Members

  • David Hennigar (79yo)

    Chairman

    • Tenure: 0yrs
  • Robert Francis

    Director

    • Tenure: 2.6yrs
  • N. Van Nest (83yo)

    CEO & Vice Chairman

    • Tenure: 2.6yrs
    • Compensation: CA$72.00k
  • Stanley Swierzewski

    Chief of Urology & Director

    • Tenure: 2.6yrs

Company Information

Aquarius Surgical Technologies Inc.'s company bio, employee growth, exchange listings and data sources


Key Information

  • Name: Aquarius Surgical Technologies Inc.
  • Ticker: ASTI
  • Exchange: CNSX
  • Founded: 1986
  • Industry: Health Care Equipment
  • Sector: Healthcare
  • Market Cap: CA$8.448m
  • Shares outstanding: 21.12m
  • Website: https://www.surgicallasersinc.com

Location

  • Aquarius Surgical Technologies Inc.
  • 89 Scollard Street
  • Toronto
  • Ontario
  • M5R 1G4
  • Canada

Listings

TickerExchangePrimary SecuritySecurity TypeCountryCurrencyListed on
AQQR.FOTCPK (Pink Sheets LLC)YesCommon SharesUSUSDJun 2017
ASTICNSX (Canadian National Stock Exchange)YesCommon SharesCACADJun 2017

Biography

Aquarius Surgical Technologies Inc., through its subsidiary, Surgical Lasers Inc., engages in the development, sale, distribution, marketing, and exploitation of laser-driven technologies in for use in sur ...


Company Analysis and Financial Data Status

All financial data provided by Standard & Poor's Capital IQ.
DataLast Updated (UTC time)
Company Analysis2019/10/20 00:31
End of Day Share Price2019/10/09 00:00
Earnings2019/06/30
Annual Earnings2019/03/31


Unless specified all financial data is based on a yearly period but updated quarterly. This is known as Trailing Twelve Month (TTM) or Last Twelve Month (LTM) Data. Learn more here.